| (-)-anisomycin | decreases expression | ISO | RGD:1604061 | 6480464 | Anisomycin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| (R)-noradrenaline | increases secretion | ISO | RGD:1604061 | 6480464 | Norepinephrine results in increased secretion of CCL5 protein | CTD | PMID:16782692 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:1604061 | 6480464 | Prazosin inhibits the reaction [Norepinephrine results in increased secretion of CCL5 protein] | CTD | PMID:16782692 |
| (S)-nicotine | increases expression | ISO | RGD:1604061 | 6480464 | Nicotine results in increased expression of CCL5 mRNA | CTD | PMID:18247414 |
| 1,4-benzoquinone | increases expression | ISO | RGD:1604061 | 6480464 | benzoquinone results in increased expression of CCL5 protein | CTD | PMID:17572062 |
| 1-chloro-2,4-dinitrobenzene | multiple interactions | ISO | RGD:69127 | 6480464 | diflorasone diacetate inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL5 protein]; more ... | CTD | PMID:15491423 |
| 1-chloro-2,4-dinitrobenzene | increases secretion | ISO | RGD:1604061 | 6480464 | Dinitrochlorobenzene results in increased secretion of CCL5 protein | CTD | PMID:20488241 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:69127 | 6480464 | Dinitrochlorobenzene results in increased expression of CCL5 protein | CTD | PMID:15491423 |
| 1-fluoro-2,4-dinitrobenzene | increases expression | ISO | RGD:69127 | 6480464 | Dinitrofluorobenzene results in increased expression of CCL5 mRNA; more ... | CTD | PMID:15719370 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:69127 | 6480464 | Ethinyl Estradiol results in decreased expression of CCL5 mRNA | CTD | PMID:12538720 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:69127 | 6480464 | Ethinyl Estradiol results in increased expression of CCL5 mRNA | CTD | PMID:15885639 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1604061 | 6480464 | [Estradiol co-treated with norethindrone acetate] results in decreased expression of CCL5 protein | CTD | PMID:16842799 |
| 17beta-estradiol | increases expression | ISO | RGD:1604061 | 6480464 | Estradiol results in increased expression of CCL5 mRNA | CTD | PMID:21185374 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1604061 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of CCL5 mRNA | CTD | PMID:17404688 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1604061 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to CCL5 enhancer] which results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:12200463 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL5 mRNA | CTD | PMID:22808131 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA | CTD | PMID:20059583 PMID:22808131 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:69127 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCL5 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69127 | 6480464 | [Tetrachlorodibenzodioxin co-treated with TNF protein] affects the expression of CCL5 mRNA; more ... | CTD | PMID:21979172 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1604061 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to CCL5 enhancer] which results in increased expression of CCL5 mRNA] | CTD | PMID:12200463 PMID:12200463 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69127 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA | CTD | PMID:20819909 PMID:18684927 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA | CTD | PMID:20059583 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69127 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCL5 mRNA | CTD | PMID:18684927 PMID:20819909 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69127 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CCL5 gene] | CTD | PMID:20819909 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1604061 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCL5 mRNA | CTD | PMID:12200463 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1604061 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of CCL5 mRNA] | CTD | PMID:14761676 |
| 2,6-di-tert-butyl-4-methylphenol | decreases expression | ISO | RGD:69127 | 6480464 | Butylated Hydroxytoluene results in decreased expression of CCL5 mRNA | CTD | PMID:19925653 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:69127 | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein; more ... | CTD | PMID:21146893 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:1604061 | 6480464 | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein] | CTD | PMID:18080321 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA] | CTD | PMID:17109745 |
| 2-naphthylamine | increases expression | ISO | RGD:1604061 | 6480464 | 2-Naphthylamine results in increased expression of CCL5 mRNA | CTD | PMID:18247414 |
| 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | RGD:1604061 | 6480464 | 4-OH-2',3,3',4',5'-pentachlorobiphenyl inhibits the reaction [Triiodothyronine results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:14761676 |
| 3,3',5-triiodo-L-thyronine | increases expression | ISO | RGD:1604061 | 6480464 | Triiodothyronine results in increased expression of CCL5 mRNA | CTD | PMID:14761676 |
| 3-methylcholanthrene | decreases expression | ISO | RGD:69127 | 6480464 | Methylcholanthrene results in decreased expression of CCL5 mRNA | CTD | PMID:20713471 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of CCL5 mRNA | CTD | PMID:19162173 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:69127 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CCL5 mRNA | CTD | PMID:19191707 |
| 4-hydroxynon-2-enal | multiple interactions | ISO | RGD:69127 | 6480464 | 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:19627980 |
| 4-nitroquinoline N-oxide | increases expression | ISO | RGD:69127 | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of CCL5 mRNA | CTD | PMID:22561872 |
| 4-nitroquinoline N-oxide | decreases expression | ISO | RGD:69127 | 6480464 | 4-Nitroquinoline-1-oxide results in decreased expression of CCL5 mRNA | CTD | PMID:22561872 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:1604061 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein results in increased expression of CCL5 mRNA] | CTD | PMID:12200463 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:69127 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:10495789 |
| acrolein | multiple interactions | ISO | RGD:69127 | 6480464 | CD8A protein promotes the reaction [Acrolein results in increased expression of CCL5 mRNA] | CTD | PMID:17950725 |
| acrolein | increases expression | ISO | RGD:69127 | 6480464 | Acrolein results in increased expression of CCL5 mRNA | CTD | PMID:17950725 |
| albuterol | multiple interactions | ISO | RGD:1604061 | 6480464 | [Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein | CTD | PMID:15679717 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:1604061 | 6480464 | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein] | CTD | PMID:18080321 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA] | CTD | PMID:17109745 |
| alexidine | decreases expression | ISO | RGD:1604061 | 6480464 | alexidine results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1604061 | 6480464 | Tretinoin results in decreased expression of CCL5 protein | CTD | PMID:17118196 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1604061 | 6480464 | Tretinoin results in increased expression of CCL5 mRNA | CTD | PMID:15498508 |
| aluminium hydroxide | increases secretion | ISO | RGD:1604061 | 6480464 | Aluminum Hydroxide results in increased secretion of CCL5 protein | CTD | PMID:18390722 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CCL5 mRNA | CTD | PMID:16483693 |
| antimycin A | decreases expression | ISO | RGD:1604061 | 6480464 | Antimycin A results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| apocynin | multiple interactions | ISO | RGD:1604061 | 6480464 | acetovanillone inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | CTD | PMID:22414048 |
| arsenite(3-) | affects expression | ISO | RGD:1604061 | 6480464 | arsenite affects the expression of CCL5 mRNA | CTD | PMID:22959463 |
| atropine | multiple interactions | ISO | RGD:69127 | 6480464 | [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein]; more ... | CTD | PMID:22245128 |
| beclomethasone | multiple interactions | ISO | RGD:1604061 | 6480464 | [Beclomethasone co-treated with Albuterol] results in decreased secretion of CCL5 protein; more ... | CTD | PMID:15679717 |
| benazepril | multiple interactions | EXP | | 6480464 | benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] | CTD | PMID:16284884 |
| benzene | increases expression | ISO | RGD:1604061 | 6480464 | Benzene results in increased expression of CCL5 protein | CTD | PMID:11306435 |
| benzene-1,2,4-triol | affects expression | ISO | RGD:1604061 | 6480464 | hydroxyhydroquinone affects the expression of CCL5 protein | CTD | PMID:17572062 |
| benzo[a]pyrene | increases expression | ISO | RGD:1604061 | 6480464 | Benzo(a)pyrene results in increased expression of CCL5 mRNA | CTD | PMID:18247414 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69127 | 6480464 | Benzo(a)pyrene results in decreased expression of CCL5 mRNA | CTD | PMID:20713471 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:69127 | 6480464 | Benzo(a)pyrene results in increased expression of CCL5 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CCL5 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69127 | 6480464 | Benzo(a)pyrene results in decreased expression of CCL5 mRNA | CTD | PMID:21569818 PMID:20713471 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69127 | 6480464 | Benzo(a)pyrene results in decreased expression of CCL5 mRNA | CTD | PMID:20713471 PMID:21569818 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1604061 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein results in increased expression of CCL5 protein] | CTD | PMID:12200463 |
| benzo[a]pyrene | increases expression | ISO | RGD:1604061 | 6480464 | Benzo(a)pyrene results in increased expression of CCL5 protein | CTD | PMID:11306435 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69127 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of CCL5 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69127 | 6480464 | Benzo(a)pyrene results in decreased expression of CCL5 mRNA | CTD | PMID:20713471 |
| beryllium sulfate | increases expression | ISO | RGD:1604061 | 6480464 | beryllium sulfate results in increased expression of CCL5 mRNA | CTD | PMID:16314022 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:1604061 | 6480464 | Glucosamine analog inhibits the reaction [IL1B results in increased secretion of CCL5 protein] | CTD | PMID:18080321 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CCL5 mRNA] | CTD | PMID:17109745 |
| bezafibrate | multiple interactions | ISO | RGD:1604061 | 6480464 | Bezafibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:12126966 |
| bezafibrate | multiple interactions | ISO | RGD:1604061 | 6480464 | Bezafibrate inhibits the reaction [TNF protein results in increased expression of CCL5 protein]; more ... | CTD | PMID:12586603 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1604061 | 6480464 | Mustard Gas results in increased expression of CCL5 protein | CTD | PMID:17620002 |
| calcium atom | increases uptake | ISO | RGD:1604061 | 6480464 | CCL5 protein results in increased uptake of Calcium | CTD | PMID:10984371 |
| calcium(0) | increases uptake | ISO | RGD:1604061 | 6480464 | CCL5 protein results in increased uptake of Calcium | CTD | PMID:10984371 |
| camptothecin | decreases expression | ISO | RGD:1604061 | 6480464 | Camptothecin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| carrageenan | increases expression | ISO | RGD:69127 | 6480464 | Carrageenan results in increased expression of CCL5 protein | CTD | PMID:12444156 |
| carrageenan | multiple interactions | EXP | | 6480464 | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein]; more ... | CTD | PMID:14654164 |
| catechol | increases expression | ISO | RGD:1604061 | 6480464 | catechol results in increased expression of CCL5 protein | CTD | PMID:17572062 |
| celecoxib | decreases expression | ISO | RGD:69127 | 6480464 | celecoxib results in decreased expression of CCL5 mRNA | CTD | PMID:12902868 |
| cephaeline | decreases expression | ISO | RGD:1604061 | 6480464 | cephaelin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| chenodeoxycholic acid | multiple interactions | ISO | RGD:1604061 | 6480464 | Bezafibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:12126966 |
| chenodeoxycholic acid | increases expression | ISO | RGD:69127 | 6480464 | Chenodeoxycholic Acid results in increased expression of CCL5 mRNA | CTD | PMID:21224055 |
| chenodeoxycholic acid | increases expression | ISO | RGD:1604061 | 6480464 | Chenodeoxycholic Acid results in increased expression of CCL5 protein; more ... | CTD | PMID:12126966 |
| ciglitazone | multiple interactions | ISO | RGD:69127 | 6480464 | ciglitazone inhibits the reaction [Thioglycolates results in increased secretion of CCL5 protein] | CTD | PMID:12624547 |
| cisplatin | multiple interactions | ISO | RGD:69127 | 6480464 | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:15814532 |
| cisplatin | increases expression | ISO | RGD:69127 | 6480464 | Cisplatin results in increased expression of CCL5 mRNA | CTD | PMID:15814532 more ... |
| cisplatin | increases expression | ISO | RGD:69127 | 6480464 | Cisplatin results in increased expression of CCL5 mRNA | CTD | PMID:20702592 more ... |
| cisplatin | increases expression | ISO | RGD:69127 | 6480464 | Cisplatin results in increased expression of CCL5 mRNA | CTD | PMID:21151649 more ... |
| cisplatin | increases expression | ISO | RGD:69127 | 6480464 | Cisplatin results in increased expression of CCL5 mRNA | CTD | PMID:21151649 more ... |
| cisplatin | multiple interactions | ISO | RGD:69127 | 6480464 | TIMD2 promotes the reaction [Cisplatin results in increased expression of CCL5 mRNA] | CTD | PMID:20702592 |
| cisplatin | increases expression | ISO | RGD:69127 | 6480464 | Cisplatin results in increased expression of CCL5 protein | CTD | PMID:15814532 |
| cisplatin | increases expression | ISO | RGD:69127 | 6480464 | Cisplatin results in increased expression of CCL5 mRNA | CTD | PMID:15814532 more ... |
| codeine | multiple interactions | ISO | RGD:1604061 | 6480464 | Codeine affects the secretion of and affects the expression of CCL5 protein | CTD | PMID:17441793 |
| copper atom | multiple interactions | ISO | RGD:1604061 | 6480464 | [Copper co-treated with Hydrogen Peroxide] promotes the reaction [CCL5 protein binds to CCL5 protein]; more ... | CTD | PMID:21963154 |
| copper atom | increases secretion | ISO | RGD:69127 | 6480464 | Copper results in increased secretion of CCL5 protein | CTD | PMID:19635393 |
| copper(0) | multiple interactions | ISO | RGD:1604061 | 6480464 | [Copper co-treated with Hydrogen Peroxide] promotes the reaction [CCL5 protein binds to CCL5 protein]; more ... | CTD | PMID:21963154 |
| copper(0) | increases secretion | ISO | RGD:69127 | 6480464 | Copper results in increased secretion of CCL5 protein | CTD | PMID:19635393 |
| cycloheximide | increases expression | ISO | RGD:1604061 | 6480464 | Cycloheximide results in increased expression of CCL5 mRNA | CTD | PMID:21146893 |
| cycloheximide | multiple interactions | ISO | RGD:1604061 | 6480464 | TNF protein promotes the reaction [Cycloheximide results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:21146893 |
| cyclosporin A | increases expression | ISO | RGD:69127 | 6480464 | Cyclosporine results in increased expression of CCL5 mRNA | CTD | PMID:19770486 |
| cyclosporin A | increases expression | ISO | RGD:69127 | 6480464 | Cyclosporine results in increased expression of CCL5 protein | CTD | PMID:21292993 |
| D-glucose | increases expression | ISO | RGD:69127 | 6480464 | Glucose results in increased expression of CCL5 mRNA | CTD | PMID:17178593 |
| D-penicillamine | increases expression | EXP | | 6480464 | Penicillamine results in increased expression of CCL5 mRNA | CTD | PMID:19575532 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1604061 | 6480464 | dasatinib results in decreased expression of CCL5 protein | CTD | PMID:17962511 |
| deoxycholic acid | increases expression | ISO | RGD:69127 | 6480464 | Deoxycholic Acid results in increased expression of CCL5 mRNA | CTD | PMID:21224055 |
| desipramine | multiple interactions | ISO | RGD:1604061 | 6480464 | Desipramine inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | CTD | PMID:17477857 |
| dexamethasone | multiple interactions | ISO | RGD:1604061 | 6480464 | Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein] | CTD | PMID:16908450 |
| dexamethasone | increases expression | ISO | RGD:69127 | 6480464 | Dexamethasone results in increased expression of CCL5 mRNA | CTD | PMID:21041162 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; more ... | CTD | PMID:18083043 |
| dexamethasone | multiple interactions | ISO | RGD:69127 | 6480464 | Dexamethasone inhibits the reaction [TNF protein results in increased expression of CCL5 protein]; more ... | CTD | PMID:10495789 |
| dichloromethane | decreases expression | EXP | | 6480464 | Methylene Chloride results in decreased expression of CCL5 mRNA | CTD | PMID:20955722 |
| diethylstilbestrol | increases expression | ISO | RGD:69127 | 6480464 | Diethylstilbestrol results in increased expression of CCL5 mRNA | CTD | PMID:21041162 |
| diflorasone diacetate | multiple interactions | ISO | RGD:69127 | 6480464 | diflorasone diacetate inhibits the reaction [Dinitrochlorobenzene results in increased expression of CCL5 protein]; more ... | CTD | PMID:15491423 |
| digitoxigenin | decreases expression | ISO | RGD:1604061 | 6480464 | Digitoxigenin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| digoxin | decreases expression | ISO | RGD:1604061 | 6480464 | Digoxin results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| dimethyl sulfoxide | multiple interactions | ISO | RGD:1604061 | 6480464 | Dimethyl Sulfoxide inhibits the reaction [[Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased secretion of CCL5 protein] | CTD | PMID:21878375 |
| disulfiram | multiple interactions | ISO | RGD:69127 | 6480464 | Disulfiram inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:19016906 |
| emetine | decreases expression | ISO | RGD:1604061 | 6480464 | Emetine results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| ethyl acetate | increases expression | ISO | RGD:1604061 | 6480464 | ethyl acetate results in increased expression of CCL5 protein | CTD | PMID:11306435 |
| ethylbenzene | decreases expression | EXP | | 6480464 | ethylbenzene results in decreased expression of CCL5 mRNA | CTD | PMID:20955722 |
| ethylene glycol | increases expression | EXP | | 6480464 | Ethylene Glycol results in increased expression of CCL5 protein | CTD | PMID:16284884 |
| ethylene glycol | multiple interactions | EXP | | 6480464 | benazepril inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein]; more ... | CTD | PMID:16284884 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:1604061 | 6480464 | Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased secretion of CCL5 protein] | CTD | PMID:21245013 |
| fenofibrate | multiple interactions | ISO | RGD:1604061 | 6480464 | Fenofibrate inhibits the reaction [Chenodeoxycholic Acid results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:12126966 |
| fenofibrate | multiple interactions | ISO | RGD:1604061 | 6480464 | Fenofibrate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:12586603 |
| fluoxetine | multiple interactions | ISO | RGD:1604061 | 6480464 | Fluoxetine inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | CTD | PMID:17477857 |
| formaldehyde | multiple interactions | ISO | RGD:69127 | 6480464 | Formaldehyde promotes the reaction [Antigens, Dermatophagoides results in increased expression of CCL5 protein] | CTD | PMID:12435080 |
| formoterol | multiple interactions | ISO | RGD:1604061 | 6480464 | [Beclomethasone co-treated with formoterol] results in decreased secretion of CCL5 protein | CTD | PMID:15679717 |
| fulvestrant | increases expression | ISO | RGD:1604061 | 6480464 | fulvestrant results in increased expression of CCL5 mRNA | CTD | PMID:12154049 |
| glucose | increases expression | ISO | RGD:69127 | 6480464 | Glucose results in increased expression of CCL5 mRNA | CTD | PMID:17178593 |
| gold atom | multiple interactions | ISO | RGD:69127 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
| gold atom | increases secretion | ISO | RGD:69127 | 6480464 | Gold results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
| gold(0) | multiple interactions | ISO | RGD:69127 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
| gold(0) | increases secretion | ISO | RGD:69127 | 6480464 | Gold results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
| heparan sulfate | multiple interactions | ISO | RGD:1604061 | 6480464 | Heparitin Sulfate inhibits the reaction [Hydrogen Peroxide results in increased degradation of CCL5 protein]; more ... | CTD | PMID:21963154 |
| hyaluronic acid | increases secretion | ISO | RGD:69127 | 6480464 | Hyaluronic Acid analog results in increased secretion of CCL5 protein | CTD | PMID:9278343 |
| hydrogen peroxide | increases degradation | ISO | RGD:1604061 | 6480464 | Hydrogen Peroxide results in increased degradation of CCL5 protein | CTD | PMID:21963154 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1604061 | 6480464 | [Copper co-treated with Hydrogen Peroxide] promotes the reaction [CCL5 protein binds to CCL5 protein]; more ... | CTD | PMID:21963154 |
| hydroquinone | increases expression | ISO | RGD:1604061 | 6480464 | hydroquinone results in increased expression of CCL5 protein | CTD | PMID:17572062 |
| hydroxytyrosol | multiple interactions | ISO | RGD:1604061 | 6480464 | [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | CTD | PMID:16797527 |
| ionomycin | multiple interactions | ISO | RGD:1604061 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL5 protein | CTD | PMID:17572062 |
| iron atom | increases expression | ISO | RGD:1604061 | 6480464 | Iron deficiency results in increased expression of CCL5 mRNA | CTD | PMID:20368581 |
| isotretinoin | multiple interactions | ISO | RGD:1604061 | 6480464 | Isotretinoin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:15972972 |
| isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of CCL5 mRNA | CTD | PMID:15972972 |
| isotretinoin | decreases expression | ISO | RGD:1604061 | 6480464 | Isotretinoin results in decreased expression of CCL5 mRNA | CTD | PMID:15972972 |
| kaempferol | multiple interactions | ISO | RGD:1604061 | 6480464 | [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | CTD | PMID:16797527 |
| ketamine | multiple interactions | ISO | RGD:69127 | 6480464 | [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein]; more ... | CTD | PMID:22245128 |
| leukotriene B4 | multiple interactions | EXP | | 6480464 | [Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4; more ... | CTD | PMID:18083043 |
| losartan | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] | CTD | PMID:16284884 |
| LY294002 | multiple interactions | ISO | RGD:69127 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] | CTD | PMID:22225513 |
| mangiferin | multiple interactions | ISO | RGD:69127 | 6480464 | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] | CTD | PMID:15135318 |
| melatonin | multiple interactions | ISO | RGD:69127 | 6480464 | Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] | CTD | PMID:22225513 |
| menadione | multiple interactions | EXP | | 6480464 | Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:19265712 |
| menadione | increases secretion | EXP | | 6480464 | Vitamin K 3 results in increased secretion of CCL5 protein | CTD | PMID:19265712 |
| menadione | increases expression | EXP | | 6480464 | Vitamin K 3 results in increased expression of CCL5 mRNA | CTD | PMID:19265712 |
| methionine sulfoximine | decreases expression | ISO | RGD:1604061 | 6480464 | Methionine Sulfoximine results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| methotrexate | multiple interactions | ISO | RGD:1604061 | 6480464 | SB 203580 promotes the reaction [Methotrexate results in increased expression of CCL5 protein] | CTD | PMID:19100307 |
| methotrexate | decreases expression | ISO | RGD:1604061 | 6480464 | Methotrexate results in decreased expression of CCL5 mRNA | CTD | PMID:17400583 |
| methotrexate | increases expression | ISO | RGD:1604061 | 6480464 | Methotrexate results in increased expression of CCL5 protein | CTD | PMID:19100307 |
| minocycline | decreases expression | ISO | RGD:1604061 | 6480464 | Minocycline results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| morphine | multiple interactions | ISO | RGD:1604061 | 6480464 | beta-funaltrexamine inhibits the reaction [Morphine results in decreased expression of CCL5 protein]; more ... | CTD | PMID:11106302 |
| morphine | decreases expression | ISO | RGD:1604061 | 6480464 | Morphine results in decreased expression of CCL5 protein | CTD | PMID:11106302 |
| mycophenolic acid | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with Mycophenolic Acid] results in decreased expression of CCL5 mRNA | CTD | PMID:10688038 |
| mycophenolic acid | decreases expression | EXP | | 6480464 | Mycophenolic Acid results in decreased expression of CCL5 mRNA | CTD | PMID:10688038 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69127 | 6480464 | Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA] | CTD | PMID:10495789 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1604061 | 6480464 | Acetylcysteine inhibits the reaction [TNF protein results in increased expression of CCL5 protein] | CTD | PMID:11167962 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:69127 | 6480464 | Methylnitrosourea results in increased expression of CCL5 mRNA | CTD | PMID:15240709 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CCL5 mRNA | CTD | PMID:20360939 |
| naloxone | multiple interactions | ISO | RGD:1604061 | 6480464 | Naloxone inhibits the reaction [Morphine results in decreased expression of CCL5 protein] | CTD | PMID:11106302 |
| nickel dichloride | increases secretion | ISO | RGD:1604061 | 6480464 | nickel chloride results in increased secretion of CCL5 protein | CTD | PMID:18437699 |
| nickel sulfate | affects expression | ISO | RGD:1604061 | 6480464 | nickel sulfate affects the expression of CCL5 mRNA | CTD | PMID:18202158 |
| nickel sulfate | increases secretion | ISO | RGD:1604061 | 6480464 | nickel sulfate results in increased secretion of CCL5 protein | CTD | PMID:16099135 |
| nitric oxide | decreases secretion | ISO | RGD:1604061 | 6480464 | Nitric Oxide results in decreased secretion of CCL5 protein | CTD | PMID:13678430 |
| nitric oxide | multiple interactions | ISO | RGD:69127 | 6480464 | [CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide; more ... | CTD | PMID:19016906 |
| oxytetracycline | decreases expression | ISO | RGD:1604061 | 6480464 | Oxytetracycline results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| ozone | decreases expression | ISO | RGD:69127 | 6480464 | Ozone results in decreased expression of CCL5 mRNA | CTD | PMID:12763052 |
| palmatine | decreases expression | ISO | RGD:1604061 | 6480464 | palmatine results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| paracetamol | affects expression | ISO | RGD:69127 | 6480464 | Acetaminophen affects the expression of CCL5 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | EXP | | 6480464 | Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:19265712 |
| paracetamol | increases expression | ISO | RGD:69127 | 6480464 | Acetaminophen results in increased expression of CCL5 mRNA | CTD | PMID:15578514 |
| PD123319 | multiple interactions | EXP | | 6480464 | PD 123319 inhibits the reaction [Ethylene Glycol results in increased expression of CCL5 protein] | CTD | PMID:16284884 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CCL5 mRNA | CTD | PMID:19162173 |
| permethrin | increases expression | EXP | | 6480464 | Permethrin results in increased expression of CCL5 protein | CTD | PMID:21616133 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1604061 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL5 protein | CTD | PMID:17572062 |
| pioglitazone | multiple interactions | ISO | RGD:69127 | 6480464 | pioglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | CTD | PMID:17015710 |
| pioglitazone | decreases response to substance | ISO | RGD:1604061 | 6480464 | pioglitazone results in decreased susceptibility to CCL5 protein | CTD | PMID:18158351 |
| pirinixic acid | multiple interactions | ISO | RGD:69127 | 6480464 | pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:15814532 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CCL5 mRNA | CTD | PMID:12832660 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CCL5 mRNA | CTD | PMID:19162173 |
| pirinixic acid | decreases expression | ISO | RGD:69127 | 6480464 | pirinixic acid results in decreased expression of CCL5 mRNA | CTD | PMID:17426115 |
| prazosin | multiple interactions | ISO | RGD:1604061 | 6480464 | Prazosin inhibits the reaction [Norepinephrine results in increased secretion of CCL5 protein] | CTD | PMID:16782692 |
| progesterone | multiple interactions | ISO | RGD:1604061 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of CCL5 mRNA | CTD | PMID:17404688 |
| propidium | decreases expression | ISO | RGD:1604061 | 6480464 | Propidium results in decreased expression of CCL5 protein | CTD | PMID:20116850 |
| prostaglandin E2 | decreases expression | ISO | RGD:1604061 | 6480464 | Dinoprostone results in decreased expression of CCL5 mRNA | CTD | PMID:16303787 |
| prostaglandin E2 | multiple interactions | ISO | RGD:69127 | 6480464 | Dinoprostone inhibits the reaction [rofecoxib results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:17667525 |
| prostaglandin E2 | multiple interactions | ISO | RGD:69127 | 6480464 | Dinoprostone inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:10495789 |
| quercetin | increases expression | ISO | RGD:69127 | 6480464 | Quercetin results in increased expression of CCL5 mRNA | CTD | PMID:16455785 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CCL5 mRNA | CTD | PMID:10688038 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | CTD | PMID:14654164 |
| quercetin | multiple interactions | ISO | RGD:1604061 | 6480464 | [Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA | CTD | PMID:16797527 |
| quercetin | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with Mycophenolic Acid] results in decreased expression of CCL5 mRNA | CTD | PMID:10688038 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | EXP | | 6480464 | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein] | CTD | PMID:14654164 |
| raloxifene | decreases expression | ISO | RGD:1604061 | 6480464 | Raloxifene results in decreased expression of CCL5 protein | CTD | PMID:16842799 |
| raloxifene | increases expression | ISO | RGD:1604061 | 6480464 | Raloxifene results in increased expression of CCL5 mRNA | CTD | PMID:12154049 |
| resveratrol | decreases expression | ISO | RGD:69127 | 6480464 | resveratrol analog results in decreased expression of CCL5 mRNA | CTD | PMID:15652768 |
| resveratrol | decreases expression | ISO | RGD:69127 | 6480464 | resveratrol results in decreased expression of CCL5 protein | CTD | PMID:17872969 PMID:21807089 |
| resveratrol | decreases expression | ISO | RGD:69127 | 6480464 | resveratrol results in decreased expression of CCL5 protein | CTD | PMID:17872969 |
| rosiglitazone | decreases response to substance | ISO | RGD:1604061 | 6480464 | rosiglitazone results in decreased susceptibility to CCL5 protein | CTD | PMID:18158351 |
| rosiglitazone | multiple interactions | ISO | RGD:69127 | 6480464 | rosiglitazone inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein] | CTD | PMID:17015710 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:1604061 | 6480464 | Buthionine Sulfoximine promotes the reaction [TNF protein results in increased expression of CCL5 protein]; more ... | CTD | PMID:11167962 |
| S-nitrosoglutathione | decreases secretion | ISO | RGD:1604061 | 6480464 | S-Nitrosoglutathione results in decreased secretion of CCL5 protein | CTD | PMID:13678430 |
| silicon dioxide | increases secretion | ISO | RGD:69127 | 6480464 | Silicon Dioxide results in increased secretion of CCL5 protein | CTD | PMID:19073995 |
| silicon dioxide | multiple interactions | ISO | RGD:69127 | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein | CTD | PMID:22155353 |
| simvastatin | increases expression | ISO | RGD:1604061 | 6480464 | Simvastatin results in increased expression of CCL5 mRNA | CTD | PMID:17183729 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CCL5 protein | CTD | PMID:17449418 |
| simvastatin | decreases expression | ISO | RGD:1604061 | 6480464 | Simvastatin results in decreased expression of CCL5 mRNA | CTD | PMID:17112859 |
| sodium chloride | increases expression | EXP | | 6480464 | Sodium Chloride results in increased expression of CCL5 protein | CTD | PMID:20232302 |
| sodium dichromate | decreases expression | ISO | RGD:69127 | 6480464 | sodium bichromate results in decreased expression of CCL5 mRNA | CTD | PMID:22155349 |
| sodium dodecyl sulfate | increases secretion | ISO | RGD:1604061 | 6480464 | Sodium Dodecyl Sulfate results in increased secretion of CCL5 protein | CTD | PMID:16099135 |
| succimer | multiple interactions | ISO | RGD:69127 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL5 mRNA | CTD | PMID:21641980 |
| sulindac | multiple interactions | ISO | RGD:1604061 | 6480464 | Sulindac inhibits the reaction [IL1B protein results in increased expression of CCL5 mRNA]; more ... | CTD | PMID:16159934 |
| tacrine | decreases expression | EXP | | 6480464 | Tacrine results in decreased expression of CCL5 mRNA | CTD | PMID:12832660 |
| tacrolimus hydrate | decreases expression | ISO | RGD:1604061 | 6480464 | Tacrolimus results in decreased expression of CCL5 mRNA | CTD | PMID:15948978 |
| tamibarotene | increases expression | ISO | RGD:1604061 | 6480464 | Am 80 results in increased expression of CCL5 mRNA; more ... | CTD | PMID:15498508 |
| tamibarotene | decreases expression | ISO | RGD:69127 | 6480464 | Am 80 results in decreased expression of CCL5 mRNA; more ... | CTD | PMID:20861477 |
| taurocholic acid | increases expression | ISO | RGD:69127 | 6480464 | Taurocholic Acid results in increased expression of CCL5 mRNA | CTD | PMID:21224055 |
| telmisartan | decreases response to substance | ISO | RGD:1604061 | 6480464 | telmisartan results in decreased susceptibility to CCL5 protein | CTD | PMID:18158351 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:69127 | 6480464 | tert-Butylhydroperoxide results in increased expression of CCL5 mRNA | CTD | PMID:15003993 PMID:14729362 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:69127 | 6480464 | tert-Butylhydroperoxide results in increased expression of CCL5 mRNA | CTD | PMID:14729362 PMID:15003993 |
| testosterone | decreases expression | ISO | RGD:69127 | 6480464 | Testosterone results in decreased expression of CCL5 mRNA | CTD | PMID:15788153 |
| tetrachloromethane | increases expression | ISO | RGD:69127 | 6480464 | Carbon Tetrachloride results in increased expression of CCL5 protein | CTD | PMID:17412915 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CCL5 mRNA | CTD | PMID:16239168 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of CCL5 mRNA | CTD | PMID:15963342 |
| titanium dioxide | increases expression | ISO | RGD:1604061 | 6480464 | titanium dioxide results in increased expression of CCL5 mRNA | CTD | PMID:19695317 |
| titanium dioxide | increases secretion | ISO | RGD:1604061 | 6480464 | titanium dioxide results in increased secretion of CCL5 protein | CTD | PMID:20005940 |
| toluene 2,4-diisocyanate | affects response to substance | ISO | RGD:1604061 | 6480464 | CCL5 gene polymorphism affects the susceptibility to Toluene 2,4-Diisocyanate | CTD | PMID:18447907 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:69127 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein | CTD | PMID:17015710 PMID:15491423 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:69127 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCL5 mRNA | CTD | PMID:11467998 PMID:12356572 |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCL5 mRNA | CTD | PMID:15823807 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:69127 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein | CTD | PMID:15491423 PMID:17015710 |
| toluene 2,4-diisocyanate | multiple interactions | ISO | RGD:69127 | 6480464 | TNF protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 mRNA] | CTD | PMID:12356572 |
| toluene 2,4-diisocyanate | increases expression | ISO | RGD:69127 | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of CCL5 mRNA | CTD | PMID:12356572 PMID:11467998 |
| toluene 2,4-diisocyanate | multiple interactions | ISO | RGD:69127 | 6480464 | Cilomilast inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein]; more ... | CTD | PMID:15491423 |
| toluene 2,4-diisocyanate | multiple interactions | ISO | RGD:69127 | 6480464 | BAY 11-7085 inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein]; more ... | CTD | PMID:17015710 |
| toluene 2,4-diisocyanate | multiple interactions | ISO | RGD:1604061 | 6480464 | Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CCL5 protein]; more ... | CTD | PMID:16908450 |
| trans-resveratrol | decreases expression | ISO | RGD:69127 | 6480464 | resveratrol analog results in decreased expression of CCL5 mRNA | CTD | PMID:15652768 |
| trans-resveratrol | decreases expression | ISO | RGD:69127 | 6480464 | resveratrol results in decreased expression of CCL5 protein | CTD | PMID:17872969 PMID:21807089 |
| trans-resveratrol | decreases expression | ISO | RGD:69127 | 6480464 | resveratrol results in decreased expression of CCL5 protein | CTD | PMID:17872969 |
| trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CCL5 mRNA | CTD | PMID:20955722 |
| troglitazone | increases expression | ISO | RGD:1604061 | 6480464 | troglitazone results in increased expression of CCL5 mRNA | CTD | PMID:19140230 |
| urethane | multiple interactions | ISO | RGD:69127 | 6480464 | [Urethane co-treated with Freund's Adjuvant] results in increased expression of CCL5 mRNA | CTD | PMID:12400877 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:1604061 | 6480464 | Ursodeoxycholic Acid analog inhibits the reaction [TNF protein promotes the reaction [Cycloheximide results in increased expression of CCL5 mRNA]] | CTD | PMID:21146893 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:69127 | 6480464 | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased secretion of CCL5 protein]; more ... | CTD | PMID:21146893 |
| vanadyl sulfate | increases expression | ISO | RGD:1604061 | 6480464 | vanadyl sulfate results in increased expression of CCL5 protein | CTD | PMID:18684396 |
| wortmannin | multiple interactions | ISO | RGD:69127 | 6480464 | wortmannin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA] | CTD | PMID:22225513 |
| wortmannin | multiple interactions | ISO | RGD:69127 | 6480464 | wortmannin inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] | CTD | PMID:19016906 |
| WR-1065 | increases expression | ISO | RGD:1604061 | 6480464 | WR 1065 results in increased expression of CCL5 mRNA | CTD | PMID:12007958 |